Oral etoposide and oral prednisone for the treatment of castration resistant prostate cancer
Author:
Funder
Shanghai Nature Science Foundation
Publisher
Wiley
Subject
General Medicine
Reference12 articles.
1. Challenges to improved therapeutics for metastatic castrate resistant prostate cancer: from recent successes and failures;Huang;J Hematol Oncol,2012
2. Efficacy of low dose ketoconazole therapy for Chinese patients with castration resistant prostate cancer;Lin;Chin Med J,2012
3. Oral chemotherapy in hormone-refractory prostate carcinoma patients unwilling to be admitted to hospital;Serretta;Urol Int,2009
4. Phase II trial of estramustine phosphate and oral etoposide in patients with hormone-refractory prostate cancer;Spitaleri;Ann Oncol,2009
5. Oral estramustine plus oral etoposide in the treatment of hormone refractory prostate cancer patients: a phase II study with a 5-year follow-up;Berruti;Urol Oncol,2005
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Mechanistic study of dual‐function inhibitors targeting topoisomerase II and Rad51‐mediated DNA repair pathway against castration‐resistant prostate cancer;The Prostate;2023-08-15
2. Etoposide Loaded SPION‐PNIPAM Nanoparticles Improve the in vitro Therapeutic Outcome on Metastatic Prostate Cancer Cells via Enhanced Apoptosis;Chemistry & Biodiversity;2020-10-15
3. Metronomic Chemotherapy: A Systematic Review of the Literature and Clinical Experience;Journal of Oncology;2019-03-20
4. Cytotoxics and Anti-angiogenics: Metronomic Therapies;Tumor Angiogenesis;2019
5. Phase 2 Study of Cyclophosphamide, Etoposide, and Estramustine in Patients With Castration-Resistant Prostate Cancer;Clinical Genitourinary Cancer;2018-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3